Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery.
Unintentional weight loss may occur spontaneously in older humans and animals. Further weight losses after surgery or illness in the older patients result in increased morbidity, mortality, and hospital readmission rate. A growing body of work has shown increased appetite and weight gain in response to administration of ghrelin, the "hunger hormone." We conducted two studies in senescent male Brown Norway rats to assess the ability of peripheral administration of ghrelin to increase body weight and food intake. One study assessed the effect of 2 wk of daily subcutaneous ghrelin administration (1 mg.kg(-1).day(-1)) to senescent rats in a baseline condition; a second study used the same administration protocol in an interventional experiment with aged rats subjected to a surgery with 10-15% blood loss as a model of elective surgery. In both studies, animals receiving ghrelin maintained their body weights, whereas control animals lost weight. Body weight stability was achieved in ghrelin-treated animals despite a lack of increase in daily or cumulative food intake in both experiments. Hormone and proinflammatory cytokine levels were measured before surgery and after 14 days of treatment. Ghrelin treatment appeared to blunt declining ghrelin levels and also to blunt cytokine increases seen in the surgical control group. The ability of peripheral ghrelin treatment to maintain body weights of senescent rats without concomitant increases in food intake may be due to its known ability to decrease sympathetic activity and metabolic rate, perhaps by limiting cytokine-driven inflammation.
Yukawa
Michi
M
Gerontology and Geriatric Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Weigle
David S
DS
Davis
Charles D
CD
Marck
Brett T
BT
Wolden-Hanson
Tami
T
D000375:Aging / Q000502:physiology*; D000818:Animals; D001823:Body Composition / Q000187:drug effects / Q000502:physiology; D001835:Body Weight / Q000187:drug effects*; D016207:Cytokines / Q000097:blood; D004435:Eating / Q000187:drug effects / Q000502:physiology; D054439:Ghrelin / Q000097:blood / Q000494:pharmacology*; D006728:Hormones / Q000097:blood; D007328:Insulin / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D020738:Leptin / Q000097:blood; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D013514:Surgical Procedures, Operative / Q000009:adverse effects*
D016207:Cytokines; D054439:Ghrelin; D006728:Hormones; D007328:Insulin; D020738:Leptin; D007334:Insulin-Like Growth Factor I